625PDPembrolizumab for advanced biliary adenocarcinoma: Results from the multicohort, phase II KEYNOTE-158 study

Title
625PDPembrolizumab for advanced biliary adenocarcinoma: Results from the multicohort, phase II KEYNOTE-158 study
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 29, Issue suppl_8, Pages -
Publisher
Oxford University Press (OUP)
Online
2018-10-23
DOI
10.1093/annonc/mdy282.009

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started